492 results on '"Lv, Tangfeng"'
Search Results
2. GGPPS Negatively Regulates the Formation of Neutrophil Extracellular Traps in Lipopolysaccharide-Induced Acute Lung Injury
3. Correction to: Efficacy and safety of anti‑PD‑1/PD‑L1‑based dual immunotherapies versus PD‑1/PD‑L1 inhibitor alone in patients with advanced solid tumor: a systematic review and meta‑analysis
4. A random survival forest-based pathomics signature classifies immunotherapy prognosis and profiles TIME and genomics in ES-SCLC patients
5. ALKBH5 promotes non-small cell lung cancer progression and susceptibility to anti-PD-L1 therapy by modulating interactions between tumor and macrophages
6. NAT10-mediated upregulation of GAS5 facilitates immune cell infiltration in non-small cell lung cancer via the MYBBP1A-p53/IRF1/type I interferon signaling axis
7. Comparative efficacy and safety of COVID-19 vaccines in phase III trials: a network meta-analysis
8. Utilizing metagenomic next-generation sequencing for pathogen detection and diagnosis in lower respiratory tract infections in real-world clinical practice
9. Efficacy and safety of anti-PD-1/PD-L1-based dual immunotherapies versus PD-1/PD-L1 inhibitor alone in patients with advanced solid tumor: a systematic review and meta-analysis
10. Comprehensive genomic and spatial immune infiltration analysis of survival outliers in extensive-stage small cell lung cancer receiving first-line chemoimmunotherapy
11. Expert consensus on the diagnosis and treatment of solid tumors with BRAF mutations
12. A novel oral TLR7 agonist orchestrates immune response and synergizes with PD-L1 blockade via type I IFN pathway in lung cancer
13. STING mediates LPS-induced acute lung injury by regulating ferroptosis
14. Exploration on the first-line treatment of ERBB2-altered advanced non-small cell lung cancer: A multicenter retrospective study
15. Immune checkpoint inhibitors alone vs immune checkpoint inhibitors—combined chemotherapy for NSCLC patients with high PD-L1 expression: a network meta-analysis
16. Neoadjuvant alectinib in locally advanced lung adenocarcinoma with anaplastic lymphoma kinase rearrangement: case series and literature review
17. Tandem CAR-T cells targeting MUC1 and PSCA combined with anti-PD-1 antibody exhibit potent preclinical activity against non-small cell lung cancer
18. Effect of intrinsic STING of CD8+T cells on self-metabolic reprogramming and anti-tumor effects.
19. The clinicopathological and prognostic significance of PD-L1 expression assessed by immunohistochemistry in lung cancer: a meta-analysis of 50 studies with 11,383 patients
20. Comparing the efficacy and safety of perioperative immunotherapy combinations for resectable non-small cell lung cancer: a systematic review and network meta-analysis
21. E3 ubiquitin ligase RNF6 promotes antiviral immune responses through enhancing the expression of interferon stimulated genes in myeloid cells
22. Synergistic antibacterial and wound-healing applications of an imidazole-based porous organic polymer encapsulated silver nanoparticles composite
23. Co-Delivery of VEGF siRNA and THPP via Metal–Organic Framework Reverses Cisplatin-Resistant Non-Small Cell Lung Cancer and Inhibits Metastasis through a MUC4 Regulating Mechanism.
24. F-circEA1 regulates cell proliferation and apoptosis through ALK downstream signaling pathway in non-small cell lung cancer
25. Blocking SphK1/S1P/S1PR1 Signaling Pathway Alleviates Lung Injury Caused by Sepsis in Acute Ethanol Intoxication Mice
26. Efficacy and safety of first-line PD-L1/PD-1 inhibitors in limited-stage small cell lung cancer: a multicenter propensity score matched retrospective study
27. Response to: Identifying optimal first-line treatment for advanced non-small cell lung carcinoma with high PD-L1 expression: a matter of debate
28. A Narrative Review: The Role of NETs in Acute Respiratory Distress Syndrome/Acute Lung Injury
29. The safety and efficacy of anti-PD-1 inhibitor-based combinational therapy in non-small cell lung cancer patients with oncogenic alterations
30. Efficacy of immunotherapy in patients with oncogene-driven non-small-cell lung cancer: a systematic review and meta-analysis
31. Expert Consensus on the Diagnosis and Treatment of NRG1/2 Gene Fusion Solid Tumors
32. PaO2/FiO2 and IL-6 are risk factors of mortality for intensive care COVID-19 patients
33. Elevated exosome-derived miRNAs predict osimertinib resistance in non-small cell lung cancer
34. Combination of computed tomography imaging-based radiomics and clinicopathological characteristics for predicting the clinical benefits of immune checkpoint inhibitors in lung cancer
35. The expression landscape of JAK1 and its potential as a biomarker for prognosis and immune infiltrates in NSCLC
36. WNT5B exerts oncogenic effects and is negatively regulated by miR-5587-3p in lung adenocarcinoma progression
37. Clinical definition of secondary resistance to immunotherapy in non‐small cell lung cancer
38. Design and Typical Application of Solar‐storage Integrated System for Tailings Ecological Restoration
39. Zebrafish in Lung Cancer Research
40. Expert consensus on the diagnosis and treatment of RET gene fusion non‐small cell lung cancer in China
41. Risk factors for symptomatic malignant pleural effusion recurrence in patients with actionable mutations in advanced lung adenocarcinoma
42. RNA sequencing enables systematic identification of platelet transcriptomic alterations in NSCLC patients
43. International expert consensus on diagnosis and treatment of lung cancer complicated by chronic obstructive pulmonary disease
44. Chinese expert consensus on the diagnosis and treatment of malignant pleural mesothelioma
45. The biology, function and clinical implications of exosomes in lung cancer
46. Plasma mtDNA Analysis Aids in Predicting Pancreatic Necrosis in Acute Pancreatitis Patients: A Pilot Study
47. Clinical impact of first‐line PD‐1 or PD‐L1 inhibitors combined with chemotherapy in extensive‐stage small cell lung cancer patients: A real‐world multicenter propensity score‐matched study
48. Efficacy of different therapies for brain metastases of non-small cell lung cancer: a systematic review and meta-analysis
49. Chinese expert consensus on the diagnosis and treatment of thymic epithelial tumors
50. Clinical significance of PD-L1 expression in serum-derived exosomes in NSCLC patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.